The technical and production capacity of our enterprise is rapidly improving, the production quality is more stable, and the sales market is growing
Begum MN, Mahtarin R, Ahmed S, Shahriar I, Hossain SR, Mia MW
In December 2024, the FDA's Pharmacy Compounding Advisory Committee declined to include it on the 503A bulk drug substances list, meaning compounding pharmacies in the United States cannot legally produce it for individual prescriptions
Ursodeoxycholic acid reduces antitumor immunosuppression by inducing CHIP-mediated TGF- degradation
Establishment of H 2 O 2 induced HaCaT cell oxidative injury model The IC 50 values of H 2 O 2 on HaCaT cell viability are within the concentration range of 412.1508.4 M, respectively (Fig
Antioxid Redox Signal 2004;6:81924